{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:22:29Z","timestamp":1759990949533},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T00:00:00Z","timestamp":1494028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s40618-017-0678-y","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T14:25:28Z","timestamp":1494080728000},"page":"889-890","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis"],"prefix":"10.1007","volume":"40","author":[{"given":"C.","family":"Cusini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"De Paola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Piantanida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,6]]},"reference":[{"key":"678_CR1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40618-016-0505-x","volume":"39","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Chiovato L, Vitti P (2016) Management of hyperthyroidism due to Graves\u2019 disease: frequently asked questions and answers (if any). J Endocrinol Invest 39:1105\u20131114","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"678_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.msard.2015.01.005","volume":"4","author":"F Sedel","year":"2015","unstructured":"Sedel F, Papeix C, Bellanger A et al (2015) High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 4(2):159\u2013169","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"678_CR3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1089\/thy.2015.0664","volume":"26","author":"G Barbesino","year":"2016","unstructured":"Barbesino G (2016) Misdiagnosis of Graves\u2019 disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid 26(6):860\u2013863","journal-title":"Thyroid"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0678-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0678-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0678-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T06:30:58Z","timestamp":1500273058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0678-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,6]]},"references-count":3,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0678-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,6]]}}}